Search the Newsreel

CBIO Options Chain — NASDAQ:CBIO

This article provides an options chain overview for Crescent Biopharma, Inc. (NASDAQ:CBIO). It outlines how users can track market movements, evaluate risks, and monitor live pricing, Greeks, and implied volatility for call and put options. The options data helps users build their own trading …

Analysts’ Top Financial Picks: Crescent Capital BDC (CCAP), Nordea Bank Abp (NBNKF)

Two analysts from KBW and Jefferies have issued bullish ratings for Crescent Capital BDC (CCAP) and Nordea Bank Abp (NBNKF), respectively. Crescent Capital BDC received a Buy rating with a $13.00 price target, while Nordea Bank Abp also got a Buy rating with a …

SAMG Q1 2026 Earnings: EPS Misses Estimates Amid Market Headwinds - ROIC Trend Report

SAMG Q1 2026 Earnings: EPS Misses Estimates Amid Market Headwinds - New Analyst Coverage

CS47Z Bond Profile — Key Metrics

This article provides key metrics for the CS47Z bond issued by Cresud S.A. The bond has a 7.0% coupon rate, an issue date of November 15, 2024, and matures on November 15, 2028. Cresud S.A. is an Argentine company involved in agricultural business and …

ACRES Commercial Realty (ACR) Projected to Release Earnings on Wednesday

CS47D Bond Risk Profile

The article provides a profile of the CS47D bond issued by Cresud S.A., detailing its risk assessment and key metrics for investors. It outlines information on credit risk, security level, inflation protection, and issuer rating to help evaluate the bond's reliability. The page also …

Cresud stock trades steady as Argentine agribusiness group focuses on diversification and real estat

Cresud, an Argentine agribusiness and real estate holding company, exhibits steady stock trading, reflecting its diversified portfolio. The company manages farmland operations, crop and beef production, and urban real estate. Its strategy focuses on balancing commodity-linked cash flows with asset-backed value, despite exposure to …

Crescent Energy (CRGY) Stock Looks Undervalued On Its 30% One Year Run

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Crescent Energy has delivered a 29.6% return over the past year, and with the stock recently closing at US$10.47, the key tension now is …

Fairmount Funds holds 16.5% of Crescent Biopharma (CBIO) after July 2026 deal

Fairmount Funds Management LLC and its affiliates, including Fairmount Healthcare Fund II L.P., now beneficially own 16.50% of Crescent Biopharma (CBIO), totaling 6,593,385 Ordinary Shares as of July 16, 2026. This increased stake follows the purchase of 853,450 Ordinary Shares and Pre-Funded Warrants for …

Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million

Fairmount Healthcare Fund II LP has acquired 853,450 ordinary shares of Crescent Biopharma at $14.5 each, increasing its total stake to 3,601,316 shares. Additionally, the fund purchased 525,897 pre-funded warrants at the same price, bringing its warrant position to 2,294,037. Tomas Kiselak, managing member …

Fairmount Funds' $12 Million Bet on Crescent Biopharma: A Strong Signal Amidst Volatility

Fairmount Funds Management, a major stakeholder and director of Crescent Biopharma (CBIO), recently invested over

Insider fund at Crescent Biopharma (NASDAQ: CBIO) buys 1.38M shares, warrants

Fairmount Healthcare Fund II L.P., an entity linked to Crescent Biopharma (NASDAQ: CBIO), recently acquired 853,450 ordinary shares and 525,897 pre-funded warrants, totaling 1.38 million share equivalents. These transactions, executed on July 16, 2026, increased Fairmount's indirect holdings to over 3.6 million ordinary shares …

Crescent Energy vs. Magnolia: Which E&P Stock Offers a Better Bet?

Choosing the right exploration and production (E&P) stock requires balancing growth potential, financial strength and resilience across commodity cycles. Crescent Energy Company CRGY and Magnolia Oil & Gas Corporation MGY have emerged as attractive independent U.S. producers, but they follow distinctly different strategies to …

New Strong Sell Stocks for July 20th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: ACRES Commercial Realty Corp. ACR is a real estate investment trust. The Zacks Consensus Estimate for its current year earnings has been revised 9.8% downward over the last 60 days. …

Crest Ventures fixes record date for ₹1 final dividend

Precision Trading with Cresud S.a.c.i.f. Y A. American Depositary Shares Each Representing Ten Shares Of Common Stock (CRESY) Risk Zones

This article analyzes Cresud S.a.c.i.f. Y A. American Depositary Shares Each Representing Ten Shares Of Common Stock (CRESY), highlighting positive near-term sentiment within a long-term strength context despite mid-term weakness. It identifies support being tested and presents three distinct AI-generated trading strategies with an …

How (CCAP) Movements Inform Risk Allocation Models

This article analyzes Crescent Capital Bdc Inc. (NASDAQ: CCAP) using AI models, identifying a positive near-term sentiment shifting towards broader weak alignment with an ongoing mid-channel oscillation pattern. It highlights an exceptional 33.0:1 risk-reward short setup targeting an 8.6% downside versus 0.3% risk, driven …

BlackRock Portfolio Management (NASDAQ: SAMG) discloses 4.7% Silvercrest stake in Class A shares

BlackRock Portfolio Management LLC has filed an amended Schedule 13G/A, disclosing a 4.7% beneficial ownership stake in Silvercrest Asset Management Group Inc.'s Class A stock. This represents 360,144 shares, with BlackRock holding sole voting power over 322,988 shares and sole dispositive power over all …

Crescent Biopharma (CBIO) Jefferies Global Healthcare Conference 2026 Summary

Crescent Biopharma (CBIO) presented at the Jefferies Global Healthcare Conference 2026, highlighting strong clinical data for HARMONi-6, validating PD-1/VEGF bispecifics, and discussing critical trial design strategies. The company provided updates on its pipeline, focusing on CR-001 as a best-in-class backbone therapy and its partnership …

Cresud S.A.C.I.F. y A. (NASDAQ:CRESY) Shares Pass Above 200-Day Moving Average - Here's What Happened

CS46X Bond Risk Profile

This article provides an overview of the CS46X bond, issued by Cresud S.A., highlighting its profile with a 1.5% coupon and an 18-JUL-2027 redemption date. It focuses on the bond's risk profile, encouraging users to assess credit risk through key metrics, security level, inflation …

Crescent Biopharma (CBIO) Proxy filing Summary

Crescent Biopharma (CBIO) has released a summary of its proxy filing ahead of its Annual General Meeting on June 2, 2026. Key proposals include the election of two Class II directors, ratification of PricewaterhouseCoopers LLP as auditor, and advisory votes on executive compensation and …

Crescent Biopharma Offering Closes With 9.4M Shares, Warrants

Crescent Biopharma (CBIO) announced the closing of its underwritten public offering, which included 9,387,896 ordinary shares and pre-funded warrants for up to 525,897 ordinary shares. The offering, priced at $14.50 per ordinary share and $14.499 per pre-funded warrant, generated approximately $143.7 million in gross …

Cresud to Pay Fourth Interest Installment on Series XLVI Notes on July 20, 2026

Cresud S.A.C.I.F. y A. (CRESY) announced it will pay the fourth interest installment on its Series XLVI fixed rate notes on July 20, 2026. These notes, with a principal of USD 28.55 million and maturing in 2027, bear a 1.50% annual interest rate. The …

Form 424B5 CRESCENT BIOPHARMA, INC.

Crescent Biopharma, Inc. is offering 8,094,793 ordinary shares and 525,897 pre-funded warrants, with an aim to raise approximately $115.9 million in net proceeds to fund clinical development of its product candidates CR-001, CR-002, and CR-003, as well as for research and development and general …

ACRES Commercial Realty Corp. to Report Results for Second Quarter 2026

ACRES Commercial Realty Corp. (NYSE: ACR) announced it will release its second-quarter 2026 results after market close on Wednesday, July 29, 2026. The company will host a live conference call and webcast on Thursday, July 30, 2026, at 10:00 a.m. Eastern Time for investors …

Crescent Energy (NYSE:CRGY) Stock Rating Upgraded by UBS Group

Crescent Biopharma (Nasdaq: CBIO) prices $125.0 million stock and warrant sale

Crescent Biopharma (Nasdaq: CBIO) has priced a public offering of ordinary shares and pre-funded warrants, aiming to raise approximately $125.0 million in gross proceeds. The offering includes 8,094,793 ordinary shares at $14.50 each and 525,897 pre-funded warrants at $14.499 each. The company expects net …

CRESCENT BIOPHARMA, INC. SEC Filing (Jul 13, 2026)

Crescent Energy Stock Rises 18% in 6 Months: Time to Buy or Stay?

Crescent Energy sets Aug. 4 Q2 call, results after Monday close

FutureCrest Acquisition Corp. (FCRS) Edges Higher in Low-Volume Trading Session - Wave Extension

Crescent Energy (CRGY) Stock Still Looks Cheap As The Market Stays Cautious

Silvercrest Asset Management Group Named to Inaugural CNBC Elite Advisors List of Top Ultra-High-Net-Worth Wealth Management Firms for 2026

Crest Ventures Expands Mumbai Redevelopment Footprint with Landmark Dadar East Cluster Project